Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

Press releases published on March 12, 2026

Mar. 12, 2026

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

Indeterminate GlobeNewswire

Mar. 12, 2026

Capricor Therapeutics Announces Late-Breaking HOPE-3 Data at the 2026 MDA Conference Demonstrating Significant Functional Benefits of Deramiocel for Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

Mar. 12, 2026

Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

Indeterminate GlobeNewswire

Mar. 12, 2026

Centre for Neuro Skills Appoints Curtis Shipman as Chief Information Officer 

Indeterminate GlobeNewswire

Mar. 12, 2026

Just Salad Opens Drive-Thru in Norwalk, Connecticut

Indeterminate GlobeNewswire

Mar. 12, 2026

Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy

Indeterminate GlobeNewswire

Mar. 12, 2026

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products

Indeterminate GlobeNewswire

Mar. 12, 2026

Easy Environmental Solutions surges to great start in first quarter of 2026

Indeterminate GlobeNewswire

Mar. 12, 2026

SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009

Indeterminate GlobeNewswire

Mar. 12, 2026

20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies

Indeterminate GlobeNewswire

Mar. 12, 2026

ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION

Indeterminate GlobeNewswire

Mar. 12, 2026

Pelthos Therapeutics to Present at 38th Annual ROTH Conference

Indeterminate GlobeNewswire

Mar. 12, 2026

FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology

Indeterminate GlobeNewswire

Mar. 12, 2026

Xilio Therapeutics Announces 1-for-14 Reverse Stock Split

Indeterminate GlobeNewswire

Mar. 12, 2026

Ultragenyx Announces Positive 36-Week Data from Phase 3 Study of DTX301 AAV8 Gene Therapy for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

Indeterminate GlobeNewswire

Mar. 12, 2026

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

Indeterminate GlobeNewswire

Mar. 12, 2026

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

Indeterminate GlobeNewswire

Mar. 12, 2026

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

Indeterminate GlobeNewswire

Mar. 12, 2026

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Indeterminate GlobeNewswire

Mar. 12, 2026

Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire